Tag Archives: Digital Health

Hot Investor Mandate 2: Healthcare-Focused VC and PE Fund Invests in North American Companies in Therapeutics, Medical Devices, Digital Health and Services

5 Apr

A private equity and venture fund is currently focused on health care investments such as therapeutics, medical devices, health care services, and digital health companies. The firm likes to invest early, generally seed-series A, as one of the earliest investors, and be involved throughout the life of the company, helping it grow and develop. The firm invests primarily in companies in North America. The firm will generally invest $250,000-$2M in the initial investment, with the potential for continuing funding. Because the firm prefers to play an active role in their portfolio companies, the firm will only invest in a limited number of companies at any given time.

The firm primarily invests in therapeutics and medical devices. Because the firm prefers to invest early, they look at companies that are still pre-clinical/in development and, for devices, will consider PMA as well as 510k devices. The firm is indication agnostic, focusing on technologies that inspire their passion. The firm will consider investing in technologies related to orphan diseases.

The firm has no specific management team requirements. Due to the firm’s active role in their portfolio companies, the firm does like to take a board seat following the investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Tags: , , , , , , , , , , , , , , , ,

Hot Investor Mandate 3: Technology Firm Establishes New Venture Fund for Investing in Early-Stage Digital Health Companies Globally

5 Apr

An operating group of a global public technology firm with an $18B market cap. The group began its venture portfolio in 2018 with investments in B-to-B software companies targeted at specific vertical markets such as healthcare. The fund invests $0.5M – 1M per company and is seeking companies raising seed to Series B rounds. The company is seeking 5 – 10 new investments to build their initial portfolio. The company prefers companies based in Canada, though as the parent firm is located in the US, UK, EU, and AU, the fund is open to invest globally.

The company is seeking healthcare IT, and they are particularly investing in technologies with a software component. The firm prefers commercial-stage companies, though is open to looking at clinical-stage companies as well. The company is indication agnostic.

The company will help companies fill management team positions, if necessary. The company prefers companies that are generating $100K – 3M in annual revenue.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Tags: , , , , , , , , , , , , ,

Hot Investor 2: Venture Arm of Swiss Foundation Invests Globally in Disruptive Medtech and Digital Health Companies in Trauma and Orthopedic Surgeries

22 Mar

A venture arm of a Switzerland-based foundation invests in start-ups that fundamentally improve patient care in the area of orthopedic, spine & trauma surgery. While the firm will invest globally, the current focus is on companies located in North America, Europe and Israel. The firm prefers to participate in Series A rounds, investing between $1-2.5M with the potential to provide additional capital in later rounds. The firm’s sole investor is their parent foundation, a surgeon-led, not-for-profit organization. The foundation has a global network of more than 16,000 healthcare professionals and scientists in over 100 countries specialized in the treatment of trauma and disorders of the musculoskeletal system.

The firm looks to fund companies with disruptive technologies in medical devices, diagnostics, and healthcare IT/digital health in the trauma and orthopedic surgery space. This includes technologies for before, during or after surgery, such as imaging, surgical tools, implantable devices and clinical data management. However, the firm is not currently looking to fund any regenerative medicine or tissue engineering applications within this space. If a medical device or diagnostic, companies should have a working prototype and preclinical data, while healthcare IT/digital health companies should have a running MVP as well as the ability to show market traction.

The firm invests in teams and companies that solve fundamental problems. The firm is looking for a clear market understanding and strong USP.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Tags: , , , , , , , , , , , , , , , ,

Digital Health: Two Panels Showcase the New Innovation Frontier at RESI X

25 Aug

By Lucy Parkinson, Director of Research, LSN

Boston is known for being the hub of the biotech world. But as software is eating the world, innovators are finding new avenues for digitization of healthcare. Some are tackling inefficiencies and bottlenecks in the healthcare delivery system; others are using big data algorithms to explore biological processes, make new discoveries, or find new signals in population health data.

RESI Boston will feature two panels that explore this collision between software and health. The Healthcare IT session will look at the current landscape in digital health investment. What kind of solutions are investors excited about, and how do they assess startups in this increasingly crowded sector?

Moderated by Michael A. Greeley, General Partner, Flare Capital Partners, the panelists are:

In Big Data in Healthcare, RESI will take a laser focused look at the new possibilities that data science is creating in biotech and health innovation. Five investors will explore what they’re looking for in a big data opportunity. The participants will be:

If you’d like to catch these panels in person, you can register for RESI now.

RESI-Boston-2016_v2

Tags: , , , ,

Newer Entries →